Photo from wikipedia
Radium‐223 (Ra‐223) dichloride is the bone‐targeted radioligand therapy that prolongs overall survival (OS) in patients with bone‐metastatic castration‐resistant prostate cancer (CRPC). We aimed to evaluate the safety and effectiveness of… Click to show full abstract
Radium‐223 (Ra‐223) dichloride is the bone‐targeted radioligand therapy that prolongs overall survival (OS) in patients with bone‐metastatic castration‐resistant prostate cancer (CRPC). We aimed to evaluate the safety and effectiveness of this treatment in real‐world practice.
Keywords:
prostate cancer;
resistant prostate;
castration resistant;
radium 223;
223 dichloride;
real world
Journal Title: International Journal of Urology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Urology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!